744
Views
8
CrossRef citations to date
0
Altmetric
Drug Evaluation

Empagliflozin/metformin fixed-dose combination: a review in patients with type 2 diabetes

, , , &
Pages 2471-2477 | Received 14 Sep 2016, Accepted 03 Nov 2016, Published online: 22 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Visnja Kokic Males & Martina Požar. (2023) How SGLT2 inhibitors interact with metformin? A molecular dynamics study. Molecular Simulation 49:9, pages 867-876.
Read now
Brian Godman, Holly McCabe, Trudy D Leong, Debjani Mueller, Antony P. Martin, Iris Hoxha, Julius C. Mwita, Godfrey Mutashambara Rwegerera, Amos Massele, Juliana de Oliveira Costa, Renata Cristina Rezende Macedo do Nascimento, Livia Lovato Pires de Lemos, Konstantin Tachkov, Petya Milushewa, Okwen Patrick, Loveline Lum Niba, Ott Laius, Israel Sefah, Suhaj Abdulsalim, Fatemeh Soleymani, Anastasia N Guantai, Loice Achieng, Margaret Oluka, Arianit Jakupi, Konstantīns Logviss, Mohamed Azmi Hassali, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Fadare, Olayinka O. Ogunleye, Zikria Saleem, Shazhad Hussain, Tomasz Bochenek, Ileana Mardare, Alian A. Alrasheedy, Jurij Furst, Dominik Tomek, Vanda Markovic-Pekovic, Enos M. Rampamba, Abubakr Alfadl, Adefolarin A Amu, Zinhle Matsebula, Thuy Nguyen Thi Phuong, Binh Nguyen Thanh, Aubrey Chichonyi Kalungia, Trust Zaranyika, Nyasha Masuka, Ioana D. Olaru, Janney Wale, Ruaraidh Hill, Amanj Kurdi, Angela Timoney, Stephen Campbell & Johanna C. Meyer. (2020) Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries. Expert Review of Pharmacoeconomics & Outcomes Research 20:1, pages 1-26.
Read now
André J. Scheen. (2018) The safety of empagliflozin plus metformin for the treatment of type 2 diabetes. Expert Opinion on Drug Safety 17:8, pages 837-848.
Read now

Articles from other publishers (5)

Ha Eun Choi, Ji Won Lee, Nam Kyung Je & Kyeong Hye Jeong. (2022) Use of SGLT2 inhibitor/metformin fixed dose combination in Korea. Korean Journal of Clinical Pharmacy 32:1, pages 13-19.
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology 199 229 .
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology 43 72 .
Peter Bramlage, Sascha R Tittel, Christian Wagner, Kerstin König, Dirk Raddatz, Rosmarie Weber-Lauffer, Diether Erath, Jost Hilgenberg, Carsten Spies, Thomas Danne, Maximilian Gabler, Johannes Foersch, Ludwin Ley & Jochen Seufert. (2020) The DIVE/DPV registries: evolution of empagliflozin use in clinical practice in Germany. BMJ Open Diabetes Research & Care 8:1, pages e001486.
Crossref
Jiaoting Chen, Sheng Zhang, Guixuan Pan, Lin Lin, Dongying Liu, Zhen Liu, Song Mei, Lijing Zhang, Zhihang Hu, Jianguo Chen, Huaxing Luo, Yin Wang, Yanfei Xin & Zhenqiang You. (2020) Modulatory effect of metformin on cardiotoxicity induced by doxorubicin via the MAPK and AMPK pathways. Life Sciences 249, pages 117498.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.